Document is current
Any future updates will be listed below
-
Authors
Dücker, Charlotte Maria
Herrmann, Martin
Boettcher, Susanne
Bauer-Carmona, Sarah
Schild, Raphael-Sebastian
Schönfeld, Lavinia
Raluy, Laia Pagerols
Reinshagen, Konrad
Schmitt, Claus Peter
Bartosova Medvid, Maria
Boettcher, Michael https://orcid.org/0000-0003-4972-9866
-
Funding
Funding for this research was provided by:
DFG (446358093)
Medizinische Fakultät Heidelberg der Universität Heidelberg
- License Information
-
More Information
Article History
Received: 28 May 2025
Revised: 17 September 2025
Accepted: 24 September 2025
First Online: 18 October 2025
Declarations
:
: MH and MB serve as Medical Advisors to Neutrolis, Cambridge, MA, USA that focuses on developing therapies against NET-related diseases. No compounds from Neutrolis were used in this study. CPS received consulting fees from Chiesi, Baxter, and Bioporto; lecture honorarium and traveling support from Chiesi; and research funding from Invizius and Baxter. Apart from that, the authors have no conflicts of interest relevant to this article to disclose.
